Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | EGFR | P00533 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.35 |
| ▸ | CDC25B | P30305 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7047394 | 1.00 | BLM (0.55) | BLMLMNAPTPN1ALOX15EGFR | |
| SCHEMBL7047501 | 1.00 | BLM (0.55) | BLMLMNAPTPN1ALOX15EGFR | |
| SCHEMBL3857379 | 0.86 | BLM (0.52) | BLMLMNAPTPN1ALOX15EGFR | |
| SCHEMBL26246047 | 0.86 | BLM (0.52) | BLMLMNAPTPN1ALOX15EGFR | |
| SCHEMBL14462537 | 0.86 | BLM (0.52) | BLMLMNAPTPN1ALOX15EGFR | |
| SCHEMBL15155441 | 0.84 | BLM (0.53) | BLMLMNAPTPN1ALOX15EGFR | |
| SCHEMBL27637407 | 0.84 | BLM (0.46) | BLMLMNAPTPN1ALOX15EGFR | |
| SCHEMBL5144833 | 0.84 | BLM (0.46) | BLMLMNAPTPN1ALOX15EGFR | |
| SCHEMBL1603012 | 0.84 | BLM (0.42) | BLMLMNAPTPN1CA12CA1 | |
| SCHEMBL29220621 | 0.83 | CA1 (0.46) | BLMLMNAKMT2ACA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8936922-B2 | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids and their use as percutaneous absorption enhancers | CHEMSMART, LLC (US) | 2015-01-20 | — | — | US | claimed |
| US-20120289725-A1 | SYNTHESIS OF FATTY ALCOHOL ESTERS OF ALPHA-HYDROXY CARBOXYLIC ACIDS AND THEIR USE AS PERCUTANEOUS ABSORPTION ENHANCERS | CHEMIC LABORATORIES, LLC | 2012-11-15 | — | — | US | claimed |
| US-20110136188-A1 | SYNTHESIS OF FATTY ALCOHOL ESTERS OF ALPHA-HYDROXY CARBOXYLIC ACIDS AND THEIR USE AS PERCUTANEOUS ABSORPTION ENHANCERS | CHEMSMART, LLC | 2011-06-09 | — | — | US | claimed |
| US-7863025-B2 | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids and their use as percutaneous absorption enhancers | CHEMIC LABORATORIES, INC. (US) | 2011-01-04 | — | — | US | claimed |
| EP-1802763-A2 | SYNTHESIS OF FATTY ALCOHOL ESTERS OF ALPHA-HYDROXY CARBOXYLIC ACIDS AND THEIR USE AS PERCUTANEOUS ABSORPTION ENHANCERS | Chemic Laboratories, Inc (US) | 2007-07-04 | — | — | EP | claimed |
| US-20070082039-A1 | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers, and topical gels for the transdermal delivery of steroids | CHEMSMART, LLC | 2007-04-12 | — | — | US | claimed |
| WO-2007038496-A2 | SYNTHESIS OF FATTY ALCOHOL ESTERS OF HYDROXY CARBOXYLIC ACIDS, THE USE OF THE SAME AS PERCUTANEOUS PERMEATION ENHANCERS | CHEMIC LABORATORIES, INC. (US) | 2007-04-05 | — | — | WO | claimed |
| WO-2006044926-A2 | SYNTHESIS OF FATTY ALCOHOL ESTERS OF α-HYDROXY CARBOXYLIC ACIDS AND THEIR USE AS PERCUTANEOUS ABSORPTION ENHANCERS | CHEMIC LABORATORIES, INC. (US) | 2006-04-27 | — | — | WO | claimed |
| US-20060084154-A1 | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids and their use as percutaneous absorption enhancers | CHEMIC LABORATORIES, LLC | 2006-04-20 | — | — | US | claimed |
| EP-1032554-B1 | CITRONELLYL AND/OR DIHYDROCITRONELLYL LACTATES, PREPARATION AND USE THEREOF | RHODIA CHIMIE SA (FR) | 2003-04-09 | — | — | EP | claimed |
| US-6458987-B1 | CITRONELLYL OR DIHYDROCITRONELLYL LACTATE, OPTICALLY ACTIVE AS REGARDS THE CARBON IN A POSITION OF THE CH.SUB.3 GROUP AND OF THE ESTER FUNCTION, FORMED BY ESTERIFICATION WITH LACTIC ACID OR SALTS | RHODIA CHIMIE (FR) | 2002-10-01 | — | — | US | claimed |
| US-8936922-B2 | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids and their use as percutaneous absorption enhancers | CHEMSMART, LLC (US) | 2015-01-20 | — | — | US | disclosed |
| US-20120289725-A1 | SYNTHESIS OF FATTY ALCOHOL ESTERS OF ALPHA-HYDROXY CARBOXYLIC ACIDS AND THEIR USE AS PERCUTANEOUS ABSORPTION ENHANCERS | CHEMIC LABORATORIES, LLC | 2012-11-15 | — | — | US | disclosed |
| US-20110136188-A1 | SYNTHESIS OF FATTY ALCOHOL ESTERS OF ALPHA-HYDROXY CARBOXYLIC ACIDS AND THEIR USE AS PERCUTANEOUS ABSORPTION ENHANCERS | CHEMSMART, LLC | 2011-06-09 | — | — | US | disclosed |
| US-7863025-B2 | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids and their use as percutaneous absorption enhancers | CHEMIC LABORATORIES, INC. (US) | 2011-01-04 | — | — | US | disclosed |
| US-6458987-B1 | CITRONELLYL OR DIHYDROCITRONELLYL LACTATE, OPTICALLY ACTIVE AS REGARDS THE CARBON IN A POSITION OF THE CH.SUB.3 GROUP AND OF THE ESTER FUNCTION, FORMED BY ESTERIFICATION WITH LACTIC ACID OR SALTS | RHODIA CHIMIE (FR) | 2002-10-01 | — | — | US | disclosed |
| US-6458987-B1 | CITRONELLYL OR DIHYDROCITRONELLYL LACTATE, OPTICALLY ACTIVE AS REGARDS THE CARBON IN A POSITION OF THE CH.SUB.3 GROUP AND OF THE ESTER FUNCTION, FORMED BY ESTERIFICATION WITH LACTIC ACID OR SALTS | RHODIA CHIMIE (FR) | 2002-10-01 | — | — | US | disclosed |
| US-6458987-B1 | CITRONELLYL OR DIHYDROCITRONELLYL LACTATE, OPTICALLY ACTIVE AS REGARDS THE CARBON IN A POSITION OF THE CH.SUB.3 GROUP AND OF THE ESTER FUNCTION, FORMED BY ESTERIFICATION WITH LACTIC ACID OR SALTS | RHODIA CHIMIE (FR) | 2002-10-01 | — | — | US | disclosed |
| EP-1032554-A1 | CITRONELLYL AND/OR DIHYDROCITRONELLYL LACTATES, PREPARATION AND USE THEREOF | RHODIA CHIMIE (FR) | 2000-09-06 | — | — | EP | disclosed |
| WO-1999059955-A1 | CITRONELLYL AND/OR DIHYDROCITRONELLYL LACTATES, PREPARATION AND USE THEREOF | RHODIA CHIMIE (FR) | 1999-11-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060084154-A1 | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids and their use as percutaneous absorption enhancers | ADH1A, ADH1C, FASN | BLM 3892/4885LMNA 1113/4885PTPN1 4862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.